Center for Drug Evaluation and Research

Center for Drug Evaluation and Research

Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture

| Importance: 9/10

Dr. Patrizia Cavazzoni, former head of the FDA’s Center for Drug Evaluation and Research (CDER), immediately transitioned to Pfizer as chief medical officer, reigniting intense debate about the pharmaceutical industry’s regulatory influence and the problematic ‘revolving …

Patrizia Cavazzoni FDA Pfizer Robert F. Kennedy Jr. Center for Drug Evaluation and Research +2 more regulatory-capture pharmaceutical-industry fda revolving-door institutional-corruption +2 more
Read more →

FDA Statistician Joan Buenconsejo Joins AstraZeneca After Overseeing Company Drug Reviews

| Importance: 7/10

Joan Buenconsejo, who led FDA analysis of medical statistics for drug reviews including AstraZeneca products in 2012-2013, joined AstraZeneca as a director and biometrics team leader in June 2014. This transition exemplifies the systemic ‘revolving door’ problem in pharmaceutical …

Joan Buenconsejo FDA AstraZeneca Center for Drug Evaluation and Research regulatory-capture pharmaceutical-industry fda revolving-door conflict-of-interest
Read more →